Baillie Gifford - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$110,049,556
-69.5%
6,814,214
-21.6%
0.10%
-67.4%
Q2 2023$360,654,256
-30.3%
8,690,464
+1.0%
0.31%
-34.3%
Q1 2023$517,414,551
-20.4%
8,603,501
-2.9%
0.47%
-31.1%
Q4 2022$650,162,811
-4.0%
8,863,842
-0.6%
0.68%
-2.9%
Q3 2022$677,300,000
+6.9%
8,914,191
-2.2%
0.70%
+7.4%
Q2 2022$633,578,000
-18.1%
9,116,230
-2.4%
0.65%
+19.9%
Q1 2022$773,890,000
+7.2%
9,340,845
-2.9%
0.54%
+36.9%
Q4 2021$721,906,000
-33.7%
9,615,168
+2.6%
0.40%
-30.4%
Q3 2021$1,088,478,000
-47.2%
9,369,705
+0.7%
0.57%
-43.4%
Q2 2021$2,063,165,000
+76.1%
9,301,081
+4.9%
1.00%
+53.4%
Q1 2021$1,171,635,000
-18.0%
8,863,932
+7.3%
0.66%
-17.7%
Q4 2020$1,429,497,000
+58.1%
8,261,075
+1.7%
0.80%
+27.8%
Q3 2020$904,355,000
+93.0%
8,124,645
+2.8%
0.62%
+74.5%
Q2 2020$468,692,000
-10.0%
7,903,720
+2.2%
0.36%
-36.7%
Q1 2020$520,983,000
-22.8%
7,736,618
-3.4%
0.56%
-13.5%
Q4 2019$674,917,000
+4.3%
8,008,982
-7.4%
0.65%
-11.4%
Q3 2019$647,117,000
+15.9%
8,653,618
-2.0%
0.74%
+24.3%
Q2 2019$558,287,000
+44.2%
8,829,449
+9.8%
0.59%
+39.6%
Q1 2019$387,263,000
+157.1%
8,039,525
+78.7%
0.42%
+116.3%
Q4 2018$150,610,000
-18.5%
4,498,524
+27.5%
0.20%
-2.0%
Q3 2018$184,821,000
+90.9%
3,527,100
+14.0%
0.20%
+92.3%
Q2 2018$96,823,000
+61.5%
3,093,395
+12.5%
0.10%
+48.6%
Q1 2018$59,942,000
+391.2%
2,749,639
+355.2%
0.07%
+366.7%
Q4 2017$12,203,000604,1170.02%
Other shareholders
NOVOCURE LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$39,681,00020.12%
HARTLINE INVESTMENT CORP/ 330,672$27,866,0005.97%
MORGAN JESS S & CO INC 52,889$4,457,0004.37%
Darsana Capital Partners LP 1,350,000$113,765,0003.88%
Rhenman & Partners Asset Management AB 350,000$29,495,0003.23%
COURAGE CAPITAL MANAGEMENT LLC 10,000$843,0002.55%
Taylor Frigon Capital Management LLC 38,073$3,208,0002.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,500$2,991,0001.08%
Granite Investment Partners, LLC 261,315$22,021,0001.04%
Nicholas Investment Partners, LP 85,835$7,233,0000.74%
View complete list of NOVOCURE LTD shareholders